ARTICLE | Company News
Chiron, Rhein Biotech in vaccine deal
May 3, 2001 7:00 AM UTC
Under an agreement to develop and market pediatric vaccines for developing countries, CHIR will provide diphtheria, tetanus, pertussis, and Haemophilus influenza type B antigens and Rhein (NMarkt:RBO)...